Back

Efficacy and safety of novel factor XIa inhibitors in acute non-cardioembolic stroke: a network meta-analysis of randomised controlled trials

29 August 2026 (10:00 - 10:10)
Organised by: Logo
Congress Presentation Part of: Integrated stroke-heart care: risk factors and outcomes Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Anisio Uchoa Leite Santana

(Brazil)

5 More presentations in this session

Presentation thumbnail
Atrial cardiomyopathy associates preferentially with cortical rather than non-cortical brain infarcts
Doctor G. Masini (Pisa, IT)
Abstract Slides
Presentation thumbnail
Trends in haemorrhagic and ischaemic stroke mortality in Poland, 2000–2023: a population-based joinpoint analysis
Associate Professor M. Burzynska (Lodz, PL)
Abstract Slides
Presentation thumbnail
Risk prediction for mortality and cardiovascular events in post-stroke patients after one year of follow-up: the Liverpool-Heart and bRain Project
Doctor S. Lam (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Exercise-based cardiac rehabilitation after stroke and the risk of incident dementia: an observational study from a global federated network
Doctor L. Serio (L'Aquila, IT)
Abstract Slides
Presentation thumbnail
Integrated stroke care and risk of recurrent stroke: Compliance with the ABCstroke pathway in Denmark
Ms M. Thaarup (Aalborg, DK)
Abstract Slides

Access the full session

Session thumbnail
Integrated stroke-heart care: risk factors and outcomes
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Factor XI inhibitors or direct oral anticoagulants in atrial fibrillation: an updated meta-analysis
1 September 2025
thumbnail
Congress Presentation
Comparative effectiveness of novel anti-hyperlipidemic drugs in adults with hyperlipidemia: a systematic review and bayesian network meta-analysis
4 April 2025
thumbnail
Congress Presentation
Randomized controlled trial of mechanical thrombectomy with anticoagulation versus anticoagulation alone for acute intermediate-high risk PE: primary outcome and functional endpoints from STORM-PE
20 March 2026
thumbnail
Congress Presentation
Optimizing antiplatelet therapy in ACS: a network meta-analysis of simplified regimens
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources